SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Dermatological map could lead to new treatments
Fri January 22nd - A newly created skin cell map offers a “huge leap” in understanding of disease and could pave the way for potential drug treatments for painful skin diseases, British researchers say. More
Half a million doctors needed for cancer surgery
Fri January 22nd - The world will need half a million more doctors in the next 20 years, just to cope with growing demand for cancer surgery, according to a major new analysis. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
OUR CLIENTS
THIS WEEK'S STORIES
NEWS FROM THE WEEK ENDING NOVEMBER 20th 2020

Previous week's news

20/11/20 - Hypertension link to social isolation during lockdown
Social isolation due to COVID-19 lockdowns is associated with an increase in blood pressure, according to a new Argentine study. More

20/11/20 - 'Anti COVID-19' nasal spray developed
A nasal spray has been developed that could protect against COVID-19, using materials that are already cleared for use in humans, British researchers have announced. More

19/11/20 - US vaccine approval draws near
Developers of the first COVID-19 vaccine will be seeking formal approval for use in the USA "within days", it has been announced. More

19/11/20 - Heart disease risk for homeless adults
Homeless adults are nearly twice as likely to have cardiovascular diseases compared with other adults, putting them at greater risk of severe coronavirus and early death, the first large-scale study of its kind has revealed. More

18/11/20 - Call for clear caffeine guidance for pregnant women
Guidance on caffeine consumption during pregnancy must be clearer, experts say today. More

17/11/20 - Blood test 'promising' for targeted drugs cancer therapy
A newly developed liquid biopsy can identify stomach or oesophageal cancer patients who could benefit from targeted treatment, according to a study published today. More

17/11/20 - Asthma risk for permanent night shift workers
Shift workers, particularly those who work nights permanently, could be at increased risk of developing moderate to severe asthma, researchers say today. More

16/11/20 - Heart attack risk for type 2 diabetes patients
Most people with type 2 diabetes are at high risk of having a heart attack or stroke, a new Spanish study has revealed. More

16/11/20 - Baricitinib could reduce COVID-19 mortality
Baricitinib, the rheumatoid arthritis drug, has shown promise as a treatment that could help to reduce COVID-19 mortality, an early-stage study has found. More

Printer friendly page Printer friendly page

CATEGORIES